Skip to content

Cardiogenic Shock Registry Mannheim

Cardiogenic Shock Registry Mannheim - CARESMA

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05575856
Acronym
CARESMA
Enrollment
350
Registered
2022-10-12
Start date
2019-06-01
Completion date
2023-12-01
Last updated
2022-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Shock

Keywords

cardiogenic shock, heart failure, cardiac arrest, shock, acute myocardial infarction

Brief summary

The study aims to investigate clinically and prognostically relevant parameters in patients with cardiogenic shock within a monocentric observational clinical register.

Detailed description

All consecutive patients with a confirmed cardiogenic shock presenting at the internal intensive care Unit (ICU) at the University of Mannheim are included in the register and followed up during ICU stay and after that. Data of patients' admission status, cause of cardiogenic shock, baseline parameters and comorbidities are collected. Extensive information about echocardiography, electrocardiography and imaging procedures are included in the register. Laboratory values, microbiological investigations, organ dysfunction and organ replacement therapies, medication, adverse events, and complications were recorded for several days during the ICU stay (days 1, 2, 3, 5, 7, and 8). Standard scores for critically ill patients were calculated for the day of admission at the ICU if available, and several time points during the ICU stay. The register includes information about the mortality during ICU stay, 30-day mortality, 6-month mortality and 1-year mortality.

Interventions

None listed

Sponsors

Universitätsmedizin Mannheim
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Cardiogenic shock according to current guidelines

Exclusion criteria

* other forms of shock not primary associated with cardiac dysfunction

Design outcomes

Primary

MeasureTime frameDescription
all-cause mortality30 daysdays

Secondary

MeasureTime frameDescription
all-cause mortalityduring hospital stay (up to 30 days)during hospital stay (up to 30 days)
ventilator-free days30 daysdays

Countries

Germany

Contacts

Primary ContactMichael Behnes, PhD
michael.behnes@umm.de0049621-3836239

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026